Hartenbach EM - Search Results

1

Familial ovarian germ cell cancer: report and review.

Stettner AR, Hartenbach EM, Schink JC, Huddart R, Becker J, Pauli R, Long R, Laxova R. Stettner AR, et al. Among authors: hartenbach em. Am J Med Genet. 1999 May 7;84(1):43-6. doi: 10.1002/(sici)1096-8628(19990507)84:1<43::aid-ajmg9>3.0.co;2-2. Am J Med Genet. 1999. PMID: 10213045

2

The role of ctDNA in endometrial cancer: A tool for risk stratification and disease monitoring.

Blitzer GC, Zhao SG, Bradley KA, Hartenbach EM. Blitzer GC, et al. Among authors: hartenbach em. Gynecol Oncol. 2023 Nov;178:170-171. doi: 10.1016/j.ygyno.2023.08.008. Epub 2023 Aug 28. Gynecol Oncol. 2023. PMID: 37648640 No abstract available.

3

The genetics of ovarian cancer: concepts in testing and counseling.

Hartenbach EM, Schink JC. Hartenbach EM, et al. Curr Opin Obstet Gynecol. 1996 Oct;8(5):339-42. Curr Opin Obstet Gynecol. 1996. PMID: 8941429 Review.

4

Trends in United States ovarian cancer mortality, 1979-1995.

Oriel KA, Hartenbach EM, Remington PL. Oriel KA, et al. Among authors: hartenbach em. Obstet Gynecol. 1999 Jan;93(1):30-3. doi: 10.1016/s0029-7844(98)00397-4. Obstet Gynecol. 1999. PMID: 9916951

5

Paclitaxel, carboplatin, and hexamethyl-melamine (taxchex) as first-line therapy for ovarian cancer.

Hartenbach EM, Harris LS, Bailey HH, Grosen EA, Larrison E, Chen D, Twiggs LB, Schink JC. Hartenbach EM, et al. Cancer J Sci Am. 1999 Nov-Dec;5(6):348-55. Cancer J Sci Am. 1999. PMID: 10606476

6

Exfoliative cytology of primary poorly differentiated (small-cell) neuroendocrine carcinoma of the uterine cervix in ThinPrep material: a case report.

Hoerl HD, Schink J, Hartenbach E, Wagner JL, Kurtycz DF. Hoerl HD, et al. Diagn Cytopathol. 2000 Jul;23(1):14-8. doi: 10.1002/1097-0339(200007)23:1<14::AID-DC3>3.0.CO;2-S. Diagn Cytopathol. 2000. PMID: 10907925

7

Outpatient vaginal cuff brachytherapy for endometrial cancer.

Petereit DG, Tannehill SP, Grosen EA, Hartenbach EM, Schink JC. Petereit DG, et al. Among authors: hartenbach em. Int J Gynecol Cancer. 1999 Nov;9(6):456-462. doi: 10.1046/j.1525-1438.1999.99061.x. Int J Gynecol Cancer. 1999. PMID: 11240811

Petereit DG, Tannehill SP, Grosen EA, Hartenbach EM, Schink JC. Outpatient vaginal cuff brachytherapy for endometrial cancer. The objective of this study was to determine the efficacy and complications of postoperative high-dose-rate (HDR) vaginal-cuff brachytherapy …

Petereit DG, Tannehill SP, Grosen EA, Hartenbach EM, Schink JC. Outpatient vaginal cuff brachytherapy for endometrial cancer. …

8

Progress of a Comprehensive Familial Cancer Genetic Counseling Program in the Era of BRCA1 and BRCA2.

Hartenbach EM, Becker JM, Grosen EA, Bailey HH, Petereit DG, Laxova R, Schink JC. Hartenbach EM, et al. Genet Test. 2002 Summer;6(2):75-8. doi: 10.1089/10906570260199311. Genet Test. 2002. PMID: 12229876

9

Long-term complications associated with the Indiana pouch urinary diversion in patients with recurrent gynecologic cancers after high-dose radiation.

Wilkin M, Horwitz G, Seetharam A, Hartenbach E, Schink JC, Bruskewitz R, Jarrard DF. Wilkin M, et al. Urol Oncol. 2005 Jan-Feb;23(1):12-5. doi: 10.1016/j.urolonc.2004.07.018. Urol Oncol. 2005. PMID: 15885577

10

Weekly docetaxel and carboplatin for recurrent ovarian and peritoneal cancer: a phase II trial.

Kushner DM, Connor JP, Sanchez F, Volk M, Schink JC, Bailey HH, Harris LS, Stewart SL, Fine J, Hartenbach EM; Wisconsin Oncology Network. Kushner DM, et al. Among authors: hartenbach em. Gynecol Oncol. 2007 May;105(2):358-64. doi: 10.1016/j.ygyno.2006.12.018. Epub 2007 Jan 29. Gynecol Oncol. 2007. PMID: 17258800 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters